Home

Publications - page 70

Search for a publication

Filter

Publication dates

Units / departments

Teams / Groups

Plateforms

Journal name

Search for a publication

12613 result(s)

2020Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathyScientific Reports
Show authors
2020Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal CancerJournal of Clinical Oncology
Show authors
2020Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancerBreast Cancer Research
Show authors
2020Novel methods for epistasis detection in genome-wide association studiesPLOS ONE
Show authors
2020MR Imaging Features to Differentiate Retinoblastoma from Coats’ Disease and Persistent Fetal VasculatureCancers
Show authors
2020PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical OutcomeInternational Journal of Molecular Sciences
Show authors
2020Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 StageCancers
Show authors
2020Insights Into the Early Gene Regulatory Network Controlling Neural Crest and Placode Fate Choices at the Neural BorderFrontiers in Physiology
Show authors
2020An in vitro Model of Human Retinal Detachment Reveals Successive Death Pathway ActivationsFrontiers in Neuroscience
Show authors
2020Trajectories, bifurcations, and pseudo-time in large clinical datasets: applications to myocardial infarction and diabetes dataGigaScience
Show authors
2020Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib TrialCancers
Show authors
2020PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast CancerFrontiers in Oncology
Show authors
2020Biological Effects of Scattered Versus Scanned Proton Beams on Normal Tissues in Total Body Irradiated Mice: Survival, Genotoxicity, Oxidative Stress and InflammationAntioxidants
Show authors
2020The Promise of Optogenetics for Bioproduction: Dynamic Control Strategies and Scale-Up InstrumentsBioengineering
Show authors
2020Deciphering the combinatorial landscape of immunityeLife
Show authors
2020VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric StudyPharmaceuticals
Show authors
2020LifeTime and improving European healthcare through cell-based interceptive medicineNature
Show authors
2020Impact of the First Wave of COVID-19 on Pediatric Oncology and Hematology: A Report from the French Society of Pediatric OncologyCancers
Show authors
2020The hippo kinase STK38 ensures functionality of XPO1Cell Cycle
Show authors
2020Vertex model instabilities for tissues subject to cellular activity or applied stressesPhysical Review E
Show authors
2020Three‐Component C–H Bond Sulfonylation of Imidazoheterocycles by Visible‐Light Organophotoredox CatalysisEuropean Journal of Organic Chemistry
Show authors
2020First person – Sarah TaheralyJournal of Cell Science
2020An image analysis method to survey the dynamics of polar protein abundance in the regulation of tip growthJournal of Cell Science
Show authors
2020Dynamical Boolean Modeling of Immunogenic Cell DeathFrontiers in Physiology
Show authors
2020Chikungunya virus superinfection exclusion is mediated by a block in viral replication and does not rely on non-structural protein 2PLOS ONE
Show authors
2020Minimum Spanning vs. Principal Trees for Structured Approximations of Multi-Dimensional DatasetsEntropy
Show authors
2020Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against RhabdomyosarcomaCancers
Show authors
2020A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumoursBritish Journal of Cancer
Show authors
2020Optimizing energetic cost of uncertainty in a driven system with and without feedbackPhysical Review E
Show authors
2020FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancerEMBO Molecular Medicine
Show authors

Previous<

1 ...69 70 71...421

Next >